Novacyt Logo

Novacyt

Develops and manufactures molecular diagnostic tests for various health markets.

ALNOV | PA

Overview

Corporate Details

ISIN(s):
FR0010397232 (+1 more)
LEI:
213800BWAC2BF295EG28
Country:
France
Address:
13 AVENUE MORANE SAULNIER, 78129 VELIZY-VILLACOUBLAY

Description

Novacyt is an international molecular diagnostics company that provides a broad portfolio of integrated technologies and services. The company's core activities include the design, development, manufacturing, and commercialization of in vitro and molecular diagnostic tests, with a specialization in real-time PCR (qPCR) kits and reagents. Novacyt's solutions are applied across various markets, including clinical diagnostics for human health, with a focus on infectious diseases and oncology, as well as animal health and food safety. The company also offers custom development services, contract manufacturing, and pharmaceutical research services such as whole genome sequencing.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-01 13:10
Liquidity Agreement Monthly Update and TVR
English 23.6 KB
2025-11-03 15:40
Liquidity Agreement Monthly Update and TVR
English 23.6 KB
2025-10-22 08:00
Strategy update & notice of investor presentation
English 26.1 KB
2025-10-01 17:00
Liquidity Agreement Monthly Update and TVR
English 24.3 KB
2025-09-18 08:00
Notice of Results
English 20.7 KB
2025-09-18 07:00
Information sur les résultats du 1er semestre 2025
French 219.8 KB
2025-09-15 08:00
Appointment of Joint Corporate Broker
English 20.9 KB
2025-09-15 07:00
Nomination d'un co-courtier pour l’entreprise
French 218.9 KB
2025-09-12 11:00
Resolution re. Lab 21 HSE Prosecution
English 22.3 KB
2025-09-12 07:00
Décision concernant les poursuites engagées par le HSE contre Lab 21
French 223.3 KB
2025-08-01 17:02
Liquidity Agreement Monthly Update & TVR
English 23.7 KB
2025-08-01 16:00
Information mensuelle sur le contrat de liquidité et sur le nombre total de dro…
French 241.0 KB
2025-07-29 08:00
Half-year trading update
English 25.1 KB
2025-07-15 08:00
Launch of LightBench® Discover
English 23.5 KB
2025-07-15 07:00
Lancement de LightBench® Discover
French 247.4 KB

Automate Your Workflow. Get a real-time feed of all Novacyt filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Novacyt

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Novacyt via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.